MétaCan
Menu
← Back to cohort

S11 The different mechanisms of inhaled and oral corticosteroids in T2-high asthma. For those established on inhaled steroids additional effects from oral steroids may lie in access to the small airways

2024· article· en· W4404046167 on OpenAlexaff
J. Mark Melhorn, C Pelaia, Gareth Hynes, Rahul Shrimanker, Laura Bermejo-Sanchez, Catherine Borg, M Mahdi, Simon Couillard, George A. Lavoie, Imran Howell, Haonan Xu, Ian Pavord, TSC Hinks

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsUniversité de Sherbrooke
Fundersnot available
KeywordsInhaled corticosteroidsAsthmaMedicineInternal medicine

Abstract

fetched live from OpenAlex

Introduction Inhaled and oral corticosteroids are cornerstone treatments of eosinophilic asthma but their differential mechanisms of action are incompletely understood. Methods We conducted a prospective observational study to examine the effects of inhaled and oral corticosteroids [REC18/SC/0361]. Participants with FeNO >45 ppb and/or blood eosinophils >0.30x109/L were selected. Cohorts comprised: (i) inhaled corticosteroid-naïve patients before/after 8 weeks beclomethasone 200 mcg twice daily (ICS group, n=21); (ii) participants with confirmed adherence to ICS treatment (geomean daily BDP equivalent dose ±SEM 949±130mcg) and abstinent of oral corticosteroids for >3 months before/after 10 days of prednisolone 30 mg daily (OCS group, n=21); (iii) healthy controls (n=31). Outcomes included lung function, symptoms, blood and sputum cell counts and levels of 12 canonical markers of type-2 inflammation assayed via ELISA. Between and within group comparisons were made using mixed effects ANOVA. Results ICS and OCS groups were matched at baseline for age, gender, atopy, bronchodilator reversibility and FeNO. Both ICS and OCS treatments resulted in significant improvements in FEV1 (figure 1A) and reduction of symptom scores (mean ACQ5 difference 1.1 with OCS and 1.5 with ICS, both p<0.001). FeNO was reduced by both ICS (mean reduction 62%, p<0.0001) and OCS (mean reduction 42%, p<0.001) with no significant between-group treatment effect (figure 1B). Introducing OCS treatment resulted in a greater reduction of blood eosinophils (76%) than initiating ICS treatment (31%) (p<0.001) and OCS reduced sputum eosinophil% by a greater margin than ICS (28.5% points vs 6.8% points, p=0.02, figure 1D). ICS treatment had no significant effect on serum mediators while OCS treatment reduced serum IL-5 only (figure 1F). Both ICS and OCS treatment reduced sputum levels of IL-5, eotaxin-3 and TSLP (all p<0.01). Sputum eotaxin was reduced uniquely by ICS (p=0.02, figure 1G) while the addition of OCS uniquely reduced sputum levels of IL-4, IL-13 and LTE4 (all p<0.04). Conclusion Our findings are consistent with an important role for the small airways in FeNO non-suppression and a site of OCS treatment response in T2-high patients. This effect might result through greater tissue bioavailability of OCS and/or in providing enhanced access for inhaled therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.086
Threshold uncertainty score0.289

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0860.009

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.294
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same topicAsthma and respiratory diseases→French-language works237,207→